Cholesterol homeostasis regulated by ABCA1 is critical for retinal ganglion cell survival.

Autor: Yang, Jialiang, Chen, Yuhong, Zou, Tongdan, Xue, Bai, Yang, Fang, Wang, Xiangzhou, Huo, Yibo, Yan, Boyun, Xu, Yuxia, He, Shiyu, Yin, Yi, Wang, Jing, Zhu, Xiong, Zhang, Lin, Zhou, Yu, Tai, Zhengfu, Shuai, Ping, Yu, Man, Luo, Qian, Cheng, Yilian
Zdroj: SCIENCE CHINA Life Sciences; Feb2023, Vol. 66 Issue 2, p211-225, 15p
Abstrakt: Genome-wide association studies have suggested a link between primary open-angle glaucoma and the function of ABCA1. ABCA1 is a key regulator of cholesterol efflux and the biogenesis of high-density lipoprotein (HDL) particles. Here, we showed that the POAG risk allele near ABCA1 attenuated ABCA1 expression in cultured cells. Consistently, POAG patients exhibited lower ABCA1 expression, reduced HDL, and higher cholesterol in white blood cells. Ablation of Abca1 in mice failed to form HDL, leading to elevated cholesterol levels in the retina. Counting retinal ganglion cells (RGCs) by using an artificial intelligence (AI) program revealed that Abca1-deficient mice progressively lost RGCs with age. Single-cell RNA sequencing (scRNA-seq) revealed aberrant oxidative phosphorylation in the Abca1−/− retina, as well as activation of the mTORC1 signaling pathway and suppression of autophagy. Treatment of Abca1−/− mice using atorvastatin reduced the cholesterol level in the retina, thereby improving metabolism and protecting RGCs from death. Collectively, we show that lower ABCA1 expression and lower HDL are risk factors for POAG. Accumulated cholesterol in the Abca1−/− retina causes profound aberrant metabolism, leading to a POAG-like phenotype that can be prevented by atorvastatin. Our findings establish statin use as a preventive treatment for POAG associated with lower ABCA1 expression. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: